Journal of Medicinal Chemistry
Journal of Medicinal Chemistry
5 years ago

Discovery of Clinical Candidate 4-[2-(5-Amino-1H-pyrazol-4-yl)-4-chlorophenoxy]-5-chloro-2-fluoro-N-1,3-thiazol-4-ylbenzenesulfonamide (PF-05089771): Design and Optimization of Diaryl Ether Aryl Sulfonamides as Selective Inhibitors of NaV1.7

Discovery of Clinical Candidate 4-[2-(5-Amino-1H-pyrazol-4-yl)-4-chlorophenoxy]-5-chloro-2-fluoro-N-1,3-thiazol-4-ylbenzenesulfonamide (PF-05089771): Design and Optimization of Diaryl Ether Aryl Sulfonamides as Selective Inhibitors of NaV1.7
Sarah J. Ransley, Zhixin Lin, Mel S. Glossop, Christopher W. West, Sebastien R. G. Galan, David J. Rawson, Steven M. Gaulier, Richard P. Butt, Shoko Nakagawa, Brian E. Marron, Marcel J. de Groot, Stephen Denton, Kosuke Sasaki, Bruce M. Bechle, R. Ian Storer, Steven M. Reister, Alan D. Brown, Mark L. Chapman, Matthew S. Johnson, Paul A. Stupple, Ian K. Gurrell, Dave Batchelor, David S. Millan, Christopher J. Markworth, Bruce Brown, Jo Hannam, Serge Beaudoin, Nigel. A. Swain, David Ellis, Ken J. Butcher, David Printzenhoff, Ben S. Greener, Andy Pike, Paul A. Bradley
A series of acidic diaryl ether heterocyclic sulfonamides that are potent and subtype selective NaV1.7 inhibitors is described. Optimization of early lead matter focused on removal of structural alerts, improving metabolic stability and reducing cytochrome P450 inhibition driven drug–drug interaction concerns to deliver the desired balance of preclinical in vitro properties. Concerns over nonmetabolic routes of clearance, variable clearance in preclinical species, and subsequent low confidence human pharmacokinetic predictions led to the decision to conduct a human microdose study to determine clinical pharmacokinetics. The design strategies and results from preclinical PK and clinical human microdose PK data are described leading to the discovery of the first subtype selective NaV1.7 inhibitor clinical candidate PF-05089771 (34) which binds to a site in the voltage sensing domain.

Publisher URL: http://dx.doi.org/10.1021/acs.jmedchem.7b00598

DOI: 10.1021/acs.jmedchem.7b00598

You might also like
Discover & Discuss Important Research

Keeping up-to-date with research can feel impossible, with papers being published faster than you'll ever be able to read them. That's where Researcher comes in: we're simplifying discovery and making important discussions happen. With over 19,000 sources, including peer-reviewed journals, preprints, blogs, universities, podcasts and Live events across 10 research areas, you'll never miss what's important to you. It's like social media, but better. Oh, and we should mention - it's free.

  • Download from Google Play
  • Download from App Store
  • Download from AppInChina

Researcher displays publicly available abstracts and doesn’t host any full article content. If the content is open access, we will direct clicks from the abstracts to the publisher website and display the PDF copy on our platform. Clicks to view the full text will be directed to the publisher website, where only users with subscriptions or access through their institution are able to view the full article.